We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ely Lilly Offers $35 Insulin Co-Pay in Response to COVID-19
Ely Lilly Offers $35 Insulin Co-Pay in Response to COVID-19
Eli Lilly yesterday introduced a $35 monthly insulin co-pay for patients with or without commercial insurance to ensure they have access to the diabetes drug during the COVID-19 crisis.